Substance / Medication

Nedocromil

Overview

Active Ingredient
nedocromil
RxNorm CUI
31563

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Nedocromil sodium for chronic asthma in children.
Sridhar A V, McKean M · Cochrane Database Syst Rev · 2006
PMID: 16856028Meta-AnalysisFull text (PMC)
Nedocromil sodium for preventing exercise-induced bronchoconstriction.
Spooner C H, Saunders L D, Rowe B H · Cochrane Database Syst Rev · 2002
PMID: 11869595Meta-Analysis
Nedocromil sodium versus cromoglycate for the pre-treatment of exercise induced bronchoconstriction in asthma.
Kelly K D, Spooner C H, Rowe B H · Cochrane Database Syst Rev · 2000
PMID: 10796684Meta-Analysis
Nedocromil sodium in the treatment of exercise-induced asthma: a meta-analysis.
Spooner C, Rowe B H, Saunders L D · Eur Respir J · 2000
PMID: 10933081Meta-Analysis
Nedocromil sodium for preventing exercise-induced bronchoconstriction.
Spooner C H, Saunders L D, Rowe B H · Cochrane Database Syst Rev · 2000
PMID: 10796616Meta-AnalysisFull text (PMC)
AMP challenge induces a decrease in FE(NO) in asthmatic subjects modulated by nedocromil.
Bruce C T, Zhao D, Yates D H et al. · Eur J Clin Invest · 2006
PMID: 17087785RCT
Dissociation in the effect of nedocromil on mannitol-induced cough or bronchoconstriction in asthmatic subjects.
Koskela Heikki O, Martens Ruth, Brannan John D et al. · Respirology · 2005
PMID: 16135166RCT
Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis.
Pitsios Constantinos, Papadopoulos Dimitrios, Kompoti Evangelia et al. · Ann Allergy Asthma Immunol · 2006
PMID: 16729779Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Nedocromil (substance)
SNOMED CT
372519004
UMLS CUI
C0068483
RxNorm CUI
31563

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.